By Dr Callie Seaman and Jamie Bartley, Cannabis Industry Council Co-Chairs As we gather together to celebrate the warmth of the holiday season, we extend our heartfelt greetings to each and every one of you. It’s been a strong year for our Council, marked by notable achievements and positive strides in our ongoing quest for […]
Read More
By Dr. Céline Nicole-de Groot of CIC member Philips Additional intercanopy lighting allows more light to penetrate to lower parts of the plant, resulting in large, heavier flowers from top to bottom canopy with a significant upgrade of side flowers. The total yield and the value per m2 also increase significantly with LED intercanopy lighting, […]
Read More
Ben Hamburger is CEO of CIC member Script Assist, a medical cannabis prescription platform enabling doctors and clinics to effortlessly prescribe. As the CEO of a digital medical cannabis prescription platform, I’d love to say that we knew the Government’s decision to allow electronic prescriptions for all Schedule II and Schedule III Controlled Drugs was […]
Read More
This letter was originally published in the Telegraph The Government is inadvertently fuelling social harm across the UK as a result of its medical cannabis policies. This is because existing regulations are driving up to 1.8 million patients eligible for prescription cannabis into the £2 billion illicit market every year. The current law states that only […]
Read More
By Dr Sunil Arora, CIC Co-Chair Prescription Working Group. Since the Government legalised medical cannabis in 2018, there have been around 1,000 patients annually receiving prescriptions on the NHS, and 20,000 private patients each year. All of these prescriptions are handled by specialist medical practitioners. However, this current model where only consultants can prescribe is […]
Read More
By James Smith, Sunil Arora, Kirsty Morrison and Elisabetta Faenza. In recent years, it has been increasingly challenging for businesses to know what exact process they should follow to be allowed to develop a cannabis medicine. However, the MHRA has recently published an article, which clarifies the current process, entitled: ‘Manufacturing Authorisations or API Registrations […]
Read More
By Dr. Gary Yates, Chair, CIC Plant Science Working Group You might say I’m something of a genetics generalist. After an undergrad degree in genetics and a PhD in molecular interactions (in plant, probiotics and pathogens), I decided to focus on photosynthesis and, eventually, cannabis. As it transpires, such a varied background of study has […]
Read More
By Katya Kowalski, Head of Operations, Volteface Despite the legalisation of medical cannabis in 2018, prescribing practices have remained low and relatively contentious within the UK clinical population. In fact less than 1% of clinicians that can prescribe, currently do. There are a variety of reasons for why medical cannabis has remained on the fringes […]
Read More
By Mike Morgan-Giles, CEO, Cannabis Industry Council The challenges of developing extensive clinical trials for cannabis are well known within the industry, but perhaps less so among policy makers, regulators, and even doctors on the periphery. A range of factors contribute to this, including high start-up costs, complex and somewhat illogical regulations, and the need […]
Read More
By MedCan, CIC member If you haven’t heard of MedCan, we’re a producer of medical cannabis in South Africa. Our claim to fame is that we were the first South African company to be granted a licence to export high THC flower. More than commercial success though, we’re focused on running a sustainable business and […]
Read More